NCT02030899 (CAP_2014) is a NA clinical trial of Cage fusion in Cervical Vertebrae, sponsored by Seoul National University Hospital.

Who is sponsoring NCT02030899?

NCT02030899 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT02030899?

Interventions in NCT02030899: Cage fusion, Plate fusion.

What condition does NCT02030899 study?

NCT02030899 studies Cervical Vertebrae, Single, Degenerative Disease.

Is NCT02030899 still recruiting?

NCT02030899 is currently completed. Last updated 17 April 2024.

Last reviewed 2024-04-17 · How we verify

NCT02030899: CAP_2014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Comparison Between the Stand-alone Cage and the Autologous Iliac Bone Graft/Anterior Plating in the Single-level Surgical Treatment of the Cervical Spine

Completed NA Last updated 17 April 2024

What this trial tests

NA trial testing Cage fusion in Cervical Vertebrae in 90 participants. Completed in 30 December 2019.

Timeline

1 December 2013

Primary endpoint
30 December 2019

30 December 2019

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	1 December 2013
Primary completion	30 December 2019
Estimated completion	30 December 2019
Sites	1 location across South Korea

Drugs / interventions tested

Cage fusion
Plate fusion

Conditions studied

Cervical Vertebrae — all drugs for Cervical Vertebrae →
Single — all drugs for Single →
Degenerative Disease — all drugs for Degenerative Disease →

Sponsor

Seoul National University Hospital

Who can join

Adults 30 to 70, any sex, with Cervical Vertebrae or Single. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of plate in addition to autologous bone is better then stand alone cage fusion regarding fusion rate and segmental lordosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02030899 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 17 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02030899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing